New Enterprise Associates 12, Limited Partnership → Viracta Therapeutics, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

7 filings by this filer

6 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other Filings by New Enterprise Associates 12, Limited Partnership

Filed	Form	Issuer	Stake	Shares
2022-01-05	SC	Liquidia Corp LQDA	—	—	view →
2021-12-29	SC	ARDELYX, INC. ARDX	—	—	view →
2021-03-11	SC	TREVENA INC	—	—	view →
2020-07-07	SC	Liquidia Technologies Inc	—	—	view →
2019-12-06	SC	PROTEOSTASIS THERAPEUTICS, INC.	—	—	view →
2018-03-06	SC	Tintri, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →